| Structure-based design of prefusion-stabilized SARS-CoV-2 spikes CL Hsieh, JA Goldsmith, JM Schaub, AM DiVenere, HC Kuo, ... Science 369 (6510), 1501-1505, 2020 | 1030 | 2020 |
| Broad neutralization of SARS-related viruses by human monoclonal antibodies AZ Wec, D Wrapp, AS Herbert, DP Maurer, D Haslwanter, M Sakharkar, ... Science 369 (6504), 731-736, 2020 | 541 | 2020 |
| The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates BE Jones, PL Brown-Augsburger, KS Corbett, K Westendorf, J Davies, ... Science translational medicine 13 (593), eabf1906, 2021 | 396 | 2021 |
| Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes WN Voss, YJ Hou, NV Johnson, G Delidakis, JE Kim, K Javanmardi, ... Science 372 (6546), 1108-1112, 2021 | 241 | 2021 |
| SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma E Andreano, G Piccini, D Licastro, L Casalino, NV Johnson, I Paciello, ... Proceedings of the National Academy of Sciences 118 (36), 2021 | 204 | 2021 |
| LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection BE Jones, PL Brown-Augsburger, KS Corbett, K Westendorf, J Davies, ... BioRxiv, 2020 | 150 | 2020 |
| Massively parallel kinetic profiling of natural and engineered CRISPR nucleases SK Jones, JA Hawkins, NV Johnson, C Jung, K Hu, JR Rybarski, JS Chen, ... Nature Biotechnology 39 (1), 84-93, 2021 | 106 | 2021 |
| Assembly and translocation of a CRISPR-Cas primed acquisition complex KE Dillard, MW Brown, NV Johnson, Y Xiao, A Dolan, E Hernandez, ... Cell 175 (4), 934-946. e15, 2018 | 91 | 2018 |
| Epigenetic cell fate in Candida albicans is controlled by transcription factor condensates acting at super-enhancer-like elements C Frazer, MI Staples, Y Kim, M Hirakawa, MA Dowell, NV Johnson, ... Nature microbiology 5 (11), 1374-1389, 2020 | 40 | 2020 |
| Expression and characterization of SARS-CoV-2 spike proteins JM Schaub, CW Chou, HC Kuo, K Javanmardi, CL Hsieh, J Goldsmith, ... Nature protocols 16 (11), 5339-5356, 2021 | 38 | 2021 |
| Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking AR Shiakolas, KJ Kramer, NV Johnson, SC Wall, N Suryadevara, ... Nature Biotechnology, 1-6, 2022 | 32 | 2022 |
| Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein AZ Wec, D Wrapp, AS Herbert, D Maurer, D Haslwanter, M Sakharkar, ... BioRxiv, 2020 | 26 | 2020 |
| Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition KJ Kramer, NV Johnson, AR Shiakolas, N Suryadevara, S Periasamy, ... Cell reports 37 (1), 109784, 2021 | 24 | 2021 |
| Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma WN Voss, YJ Hou, NV Johnson, JE Kim, G Delidakis, AP Horton, ... BioRxiv, 2020 | 5* | 2020 |
| Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking AR Shiakolas, N Johnson, KJ Kramer, N Suryadevara, D Wrapp, ... bioRxiv, 2021 | 4 | 2021 |
